Pre-Transplant Toxoplasma gondii Seropositivity Among Heart Transplant Recipients Is Associated With an Increased Risk of All-Cause and Cardiac Mortality

Journal of the American College of Cardiology

Volumn 50, Issue 20, 2007, Pages 1967-1972

  Arora, Satish ^a   Jenum, Pål A ^a,b   Aukrust, Pål ^a   Rollag, Halvor ^a,c   Andreassen, Arne K ^a   Simonsen, Svein ^a   Gude, Einar ^a   Fiane, Arnt E ^a   Geiran, Odd ^a,c   Gullestad, Lars ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b Hospital of Asker and Baerum   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; COTRIMOXAZOLE; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GAMMA INTERFERON; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOGLOBULIN G; INTERLEUKIN 12; INTERLEUKIN 17; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS;

ACUTE GRAFT REJECTION; ADOLESCENT; ADULT; AGED; ARTICLE; CARDIAC ALLOGRAFT VASCULOPATHY; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; HEART TRANSPLANTATION; HELPER CELL; HUMAN; IMMUNOASSAY; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; MORTALITY; PNEUMOCYSTOSIS; PRIORITY JOURNAL; PROPHYLAXIS; SEROLOGY; TOXOPLASMA GONDII; TOXOPLASMOSIS;

ADOLESCENT; ADULT; AGED; ANIMALS; CARDIOVASCULAR DISEASES; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TISSUE DONORS; TOXOPLASMA; TOXOPLASMOSIS;

EID: 35748976842     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2007.07.068     Document Type: Article

References (11)

1. Hognestad A., Endresen K., Wergeland R., et al. Plasma C-reactive protein as a marker of cardiac allograft vasculopathy in heart transplant recipients. J Am Coll Cardiol 42 (2003) 477-482
2. Hussain T., Burch M., Fenton M.J., et al. Positive pretransplantation cytomegalovirus serology is a risk factor for cardiac allograft vasculopathy in children. Circulation 115 (2007) 1798-1805
3. Scharton-Kersten T.M., Wynn T.A., Denkers E.Y., et al. In the absence of endogenous IFN-gamma, mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection. J Immunol 157 (1996) 4045-4054
4. Koh K.P., Wang Y., Yi T., et al. T cell-mediated vascular dysfunction of human allografts results from IFN-gamma dysregulation of NO synthase. J Clin Invest 114 (2004) 846-856
5. Jenum P.A., Kapperud G., Stray-Pedersen B., Melby K.K., Eskild A., and Eng J. Prevalence of Toxoplasma gondii specific immunoglobulin G antibodies among pregnant women in Norway. Epidemiol Infect 120 (1998) 87-92
6. Costanzo M.R., Naftel D.C., Pritzker M.R., et al. Heart transplant coronary artery disease detected by coronary angiography: a multiinstitutional study of preoperative donor and recipient risk factors. Cardiac Transplant Research Database. J Heart Lung Transplant 17 (1998) 744-753
7. van Loosdregt J., van Oosterhout M.F., Bruggink A.H., et al. The chemokine and chemokine receptor profile of infiltrating cells in the wall of arteries with cardiac allograft vasculopathy is indicative of a memory T-helper 1 response. Circulation 114 (2006) 1599-1607
8. Yi T., Cuchara L., Wang Y., et al. Human allograft arterial injury is ameliorated by sirolimus and cyclosporine and correlates with suppression of interferon-gamma. Transplantation 81 (2006) 559-566
9. Antonysamy M.A., Fanslow W.C., Fu F., et al. Evidence for a role of IL-17 in alloimmunity: a novel IL-17 antagonist promotes heart graft survival. Transplant Proc 31 (1999) 93
10. Veldhoen M., Hocking R.J., Atkins C.J., Locksley R.M., and Stockinger B. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24 (2006) 179-189
11. Woodman J.P., Dimier I.H., and Bout D.T. Human endothelial cells are activated by IFN-gamma to inhibit Toxoplasma gondii replication. Inhibition is due to a different mechanism from that existing in mouse macrophages and human fibroblasts. J Immunol 147 (1991) 2019-2023